Lymphoepithelioma
Lymphoepithelioma

Lymphoepithelioma is a type of cancer that arises from the epithelial cells and is characterized by a prominent infiltration of lymphocytes. It is most commonly associated with the nasopharynx, but can also occur in other locations such as the salivary glands, thymus, and skin.
Pathophysiology
Lymphoepithelioma is a subtype of undifferentiated carcinoma and is often linked to Epstein-Barr virus (EBV) infection, particularly in nasopharyngeal cases. The tumor is composed of poorly differentiated epithelial cells intermixed with a dense lymphoid stroma. The presence of lymphocytes is a hallmark of this type of cancer and contributes to its name.
Clinical Presentation
Patients with lymphoepithelioma may present with symptoms depending on the location of the tumor. In the nasopharynx, common symptoms include nasal obstruction, epistaxis, and hearing loss due to Eustachian tube dysfunction. In other locations, symptoms may vary but often include a mass or swelling.
Diagnosis
Diagnosis of lymphoepithelioma typically involves a combination of imaging studies, such as CT scan or MRI, and histopathological examination of a biopsy specimen. The biopsy will reveal the characteristic undifferentiated epithelial cells and lymphoid infiltrate. Immunohistochemistry and EBV testing may also be used to support the diagnosis.
Treatment
The treatment of lymphoepithelioma depends on the location and stage of the tumor. Common treatment modalities include radiation therapy, chemotherapy, and surgical resection. In nasopharyngeal lymphoepithelioma, radiation therapy is often the primary treatment due to the tumor's radiosensitivity.
Prognosis
The prognosis for patients with lymphoepithelioma varies based on the tumor's location and stage at diagnosis. Nasopharyngeal lymphoepithelioma generally has a better prognosis compared to other types of nasopharyngeal carcinoma, especially when detected early and treated appropriately.
Related Pages
| Oncology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This oncology-related article is a stub.
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian